LMTK2 as Potential Biomarker for Stratification between Clinically Insignificant and Clinically Significant Prostate Cancer

Figure 1

Gene expression (a), MSMB single nucleotide (SNP) (b), and PSA density (PSAd) (c) analysis in control subjects, patients with BPD, and patients with PC stratified to ciPC and csPC. Whiskers of boxplot denote nonoutlier range. Open circles denote the outliers. Expression levels of selected genes were normalised to ACTB (a, b). Arrows above box plots indicate the significant results (p value) of post hoc analysis following ANOVA on ranks (a, c) or p value of Mann–Whitney U test (b). ; ; ; lg(PSAd) denotes logarithm of base 10 for PSA density value, ng/ml.

(a)

(b)

(c)